Dudediligence.

McKesson Corporation

MCKNYSE · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$93.65BSep ’24$95.29BDec ’24$90.82BMar ’25$97.83BJun ’25$103.2BSep ’25$106.2BDec ’25$96.30BMar ’26$105.4BJun ’26
Net income, by quarter
$241.0MSep ’24$879.0MDec ’24$1.26BMar ’25$784.0MJun ’25$1.11BSep ’25$1.19BDec ’25$1.68BMar ’26$614.0MJun ’26
Fiscal years, by the month each ended
LineMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue$264.0B$276.7B$309.0B$359.1B$403.4B
Gross profit$13.13B$12.36B$12.83B$13.32B$14.55B
Operating income$2.04B$4.38B$3.91B$4.42B$6.21B
Net income$1.11B$3.56B$3.00B$3.29B$4.76B
Operating cash flow$4.43B$5.16B$4.31B$6.08B$6.16B
Free cash flow$4.05B$4.77B$3.88B$5.55B$5.72B
Cash$3.53B$4.68B$4.58B$5.69B$3.98B
Debt$5.88B$5.59B$5.63B$5.65B$7.79B
Shares outstanding275.0M277.0M278.0M279.0M280.0M